Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome

European Heart Journal

Volumn 19, Issue 3, 1998, Pages 500-507

  Yamada, M ^b   Elliott, P M ^a   Kaski, J C ^a   Prasad, K ^c   Gane, J N ^a   Lowe, C M ^a   Doi, Y ^b   McKenna, W J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c NONE

Author keywords

Hypertrophic cardiomyopathy; Prognosis; Thallium 201

Indexed keywords

AMIODARONE; DIPYRIDAMOLE; THALLIUM 201;

ADOLESCENT; ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNCOPE; THICKNESS; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DIPYRIDAMOLE; HUMANS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0032030685     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0769     Document Type: Article

References (27)

1. [1] McKenna WJ, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy. Role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532-8.
2. [2] Maron BJ, Wolfson MS, Epstein SE, Roberts WC. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-57.
3. [3] Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75: 1130-9.
4. [4] Cannon RO, Rosing DR, Maron BJ et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985; 71: 234-43.
5. [5] Elliott PM, Rosano GMC, Gill JS, Poole-Wilson PA, Kaski JC, McKenna WJ. Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy and chest Pain. Heart 1996; 75: 179-83.
6. [6] Cannon RO, Dilsizian V, O'Gara PT et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991; 83: 1660-7.
7. [7] O'Gara PT, Bonow RO, Maron BJ et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987; 76: 1214-23.
8. [8] Rubin KA, Morrison J, Padnick MB et al. Idiopathic hypertrophic subaortic stenosis: evaluation of anginal symptoms with thallium-201 myocardial imaging. Am J Cardiol 1979; 44: 1040-5.
9. [9] Von Dohlen TW, Prisant LM, Frank MJ. Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol 1989; 64: 498-503.
10. [10] Pitcher D, Wainwright R, Maisey M., Curry P, Sowton E. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J 1980; 44: 650-6.
11. [11] Hanrath P, Montz R, Mathey D et al. Correlation between myocardial thallium-201 kinetics, myocardial lactate metabolism and coronary angiographic findings in hypertrophic cardiomyopathy. Zeitschrift fur Kardiologie 1980; 69: 353-9.
12. [12] Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804.
13. [13] Report of the WHO/IFSC task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-3.
14. [14] Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-28.
15. [15] Teichholz LE, Cohen MV, Sonnenblick EH, Gorlin R. Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med 1974; 291: 1220-6.
16. [16] Chikamori T, Counihan PJ, Doi YL et al. Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol 1992; 19: 507-12.
17. [17] Blackie SP, Fairbarn MS, McElvaney GN, Morrison NJ, Wilcox PG, Pardy RL. Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age. Am Rev Respir Dis 1989; 139: 1424-9.
18. [18] Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of exercise testing and interpretation. Philadelphia: Lea and Febiger 1987; 73.
19. [19] Frenneaux MP, Counihan PJ, Caforio A, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hyertrophic cardiomyopathy. Circulation 1990; 82: 1995-2002.
20. [20] Gould KL. Non-invasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. Am J Cardiol 1978; 41: 267-78.
21. [21] O'Gorman DJ, Sheridan DJ. Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci 1991; 81: 703-13.
22. [22] Scheler S, Motz W, Strauer BE. Transient myocardial ischaemia in hypertensives: the missing link with left ventricular hypertrophy. Eur Heart J 13; 13 (Suppl D): 62-65.
23. [23] Camici P, Chiriatti G, Lorenzoni R et al. Coronary vasodilatation is impaired in both hypertrophied and non hypertrophied myocadium of patients with hypertrophic cardiomyopathy: A study with Nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991; 17: 879-86.
24. [24] Maddahi J, Abdulla A, Garia EV, Swan HJC, Berman DS. Noninvasive indentification of left main and triple vessel coronary artery disease: Improved accuracy using quantitative analysis of regional myocardial stress distribution and washout of thallium-201. J Am Coll Cardiol 1986; 7: 53-6.
25. [25] Hoffman JI. Transmural myocardial perfusion. Progress in Cardiovascular. Diseases 1987; XXIX: 429-64.
26. [26] Camici PG, Cecchi F, Gistri R et al. Dipyridamole induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron emission tomography. Coronary Artery Disease 1991; 2: 837-41.
27. [27] Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-6.